Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
10 Sep 2017 ESMO 2017: First KEYNOTE-028 Report of Pembrolizumab Activity in Patients with PD-L1-positive pNETs and Carcinoid Tumours Endocrine and neuroendocrine tumours - Cancer Immunology and Immunotherapy
10 Sep 2017 ESMO 2017: Immune Landscape of PanNETs Endocrine and neuroendocrine tumours - Pathology/Molecular biology
10 Sep 2017 ESMO 2017: Improved Survival Demonstrated with NSCLC-chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma with RB1 Wild-type Endocrine and neuroendocrine tumours - Translational research
10 Sep 2017 ESMO 2017: Location of the Primary Tumour, but not KRAS Mutations, May Indicate SIRT Survival Benefit in mCRC Gastrointestinal cancers
10 Sep 2017 ESMO 2017: Pembrolizumab Continues to Show Greater Benefit over Chemotherapy in Recurrent, Advanced Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
10 Sep 2017 ESMO 2017: Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment for Advanced or Metastatic RCC Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Combined Abemaciclib with NSAI Show Significant Clinical Benefit as Initial Treatment for Patients with HR-positive/HER2-negative ABC at Interim Analysis Breast cancer - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Ramucirumab Improves PFS in Patients with Platinum Refractory Advanced Urothelial Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Biomarker Analysis Reveals Different Genes are Upregulated After Lenvatinib and Sorafenib Treatment in Unresected HCC Gastrointestinal cancers - Translational research
10 Sep 2017 ESMO 2017: Biosimilar Rituximab Shows Equivalent Efficacy to Reference Rituximab in Previously Untreated Advanced Follicular Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Patients Receiving Radioactive Iodine for Well-Differentiated Thyroid Cancer Have an Increased Risk of AML Haematologic malignancies
10 Sep 2017 ESMO 2017: Strong Association Exists Between Tumour Type and Survival in Early Breast Cancer Breast cancer
10 Sep 2017 ESMO 2017: Genomic Landscape of Patients with TNBC and Disease Recurrence Investigated Breast cancer - Translational research
10 Sep 2017 ESMO 2017 Press Release: Licensing and Reimbursement Discrepancies Impact Patient Access to Cancer Treatment
10 Sep 2017 ESMO 2017 Press Release: Abdominal Fat a Key Cancer Driver for Postmenopausal Women